RIVAROXABAN REDUCES THE RISK OF RENAL ADVERSE OUTCOMES COMPARED WITH VITAMIN K ANTAGONISTS IN PATIENTS WITH ATRIAL FIBRILLATION - RESULTS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Pham, Hung Manh
Sy, Hoang Van
Tri, Ho Huynh Quang
That, Minh Ton
Phan, Phong Dinh
Nguyen, Hai Hoang
Tran, Song Giang
Cao, Son Luong
Vu, Quynh Nga
Pham, Hung N.
机构：
[1] Vietnam Heart Inst, Bach Mai Hosp, Hanoi, Vietnam
[2] Vietnam Heart Assoc, Hanoi, Vietnam
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1001-13
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] ASSESSING RENAL OUTCOMES IN ATRIAL FIBRILLATION PATIENTS WITH PRE-EXISTING RENAL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RIVAROXABAN VERSUS VITAMIN K ANTAGONISTS
    Hoang Van Sy
    Minh Ton That
    Ho Huynh Quang Tri
    Hai Hoang Nguyen
    Son Luong Cao
    Song Giang Tran
    Hung Manh Pham
    Phong Dinh Phan
    Pham, Hung N.
    Quynh Nga Vu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 76 - 76
  • [2] Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis
    Lopes, L. C.
    Spencer, F. A.
    Neumann, I.
    Ventresca, M.
    Ebrahim, S.
    Zhou, Q.
    Bhatnaga, N.
    Schulman, S.
    Eikeboom, J.
    Guyatt, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) : 367 - 375
  • [3] DOES RIVAROXABAN REDUCE THE DEVELOPMENT OF RENAL FAILURE COMPARED TO VITAMIN K ANTAGONIST USE IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS? A SYSTEMATIC REVIEW AND META-ANALYSIS
    Costa, O.
    Baker, W.
    Coleman, C.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 652 - 652
  • [4] Evaluating Renal Benefits of Rivaroxaban Versus Vitamin K Antagonists in Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-world Evidence
    Dinh, Phong Phan
    Ho, Tri Huynh Quang
    Pham, Hung Manh
    Nguyen, Hai Hoang
    Ton, Minh That
    Tran, Giang Song
    Vu, Nga Quynh
    Pham, Hung Nhu
    Cao, Son Luong
    Hoang, Sy Van
    EUROPEAN CARDIOLOGY REVIEW, 2024, 19
  • [5] Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis
    Vamos, Mate
    Cappato, Riccardo
    Marchlinski, Francis E.
    Natale, Andrea
    Hohnloser, Stefan H.
    EUROPACE, 2016, 18 (12): : 1787 - 1794
  • [6] Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis
    Van Der Meersch, Hans
    De Bacquer, Dirk
    De Vriese, An S.
    AMERICAN HEART JOURNAL, 2017, 184 : 37 - 46
  • [7] Cerebral microbleeds and risk of adverse outcomes in patients with atrial fibrillation: a systematic review and meta-analysis
    Corica, B.
    Romiti, G. F.
    Raparelli, V.
    Cangemi, R.
    Basili, S.
    Proietti, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 448 - 448
  • [8] Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis
    Carlos Escobar
    Vivencio Barrios
    Gregory Y. H. Lip
    Alpesh N. Amin
    Ariadna Auladell-Rispau
    Marilina Santero
    Josefina Salazar
    Carolina Requeijo
    Clinical Drug Investigation, 2021, 41 : 941 - 953
  • [9] Safety of Rivaroxaban versus Vitamin K Antagonists: A Systematic Review and Meta-Analysis
    Wasserlauf, Guila
    Grandi, Sonia M.
    Filion, Kristian B.
    Eisenberg, Mark J.
    CIRCULATION, 2012, 126 (21)
  • [10] Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis
    Escobar, Carlos
    Barrios, Vivencio
    Lip, Gregory Y. H.
    Amin, Alpesh N.
    Auladell-Rispau, Ariadna
    Santero, Marilina
    Salazar, Josefina
    Requeijo, Carolina
    CLINICAL DRUG INVESTIGATION, 2021, 41 (11) : 941 - 953
12345